Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: The ANRS HC32 QUATTRO study
European Journal of Gastroenterology & Hepatology | Feb 16, 2018
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease
European Journal of Gastroenterology & Hepatology | Feb 16, 2018
Most read this week